Stocks · Health care · Biological Products, (No Diagnostic Substances)

Agomab Therapeutics NV

AGMB
Belgium Fiscal year ends December CIK 0002020932
$9.08 -1.52% Close, 9 Oct 2026
Price $9.08 −11.07% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 6 Feb 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for AGMB. They arrive with the nightly refresh; a company joins the screen the first time one is.